QWOcollagenase clostridium histolyticum-aaes

FDA approved the original biologics license application for QWO on July 6, 2020, sponsored by ENDO GLOBAL AESTHETICS LTD. FDA’s record shows no approved efficacy supplement on the application since.

Application

BLA761146

Sponsor

ENDO GLOBAL AESTHETICS LTD

Original approval

July 6, 2020

Review

standard review

Submission class

TYPE 10- BLA

Active ingredient

collagenase clostridium histolyticum-aaes

Browse every approval whose brand starts with Q, or the complete response letters FDA has published — the applications it did not approve.

Products under this application

Approved efficacy supplements

An efficacy supplement is how a sponsor asks FDA to approve a change that needs clinical evidence — most often a new indication. FDA’s record gives each one a submission number, a date and a review priority. It does not say what any supplement approved, so neither does this page. The approval letter and label for each are on accessdata.fda.gov under the application number.

FDA’s record shows no approved efficacy supplement on this application.

Source: FDA’s Drugs@FDA application file, via openFDA (export 2026-09-03). Every field on this page comes from that record.